BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

508 related articles for article (PubMed ID: 18813785)

  • 1. Glycolysis module activated by hypoxia-inducible factor 1alpha is related to the aggressive phenotype of hepatocellular carcinoma.
    Hamaguchi T; Iizuka N; Tsunedomi R; Hamamoto Y; Miyamoto T; Iida M; Tokuhisa Y; Sakamoto K; Takashima M; Tamesa T; Oka M
    Int J Oncol; 2008 Oct; 33(4):725-31. PubMed ID: 18813785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative analysis of hepatic hypoxia-inducible factor-1alpha and its abnormal gene expression during the formation of hepatocellular carcinoma.
    Yao DF; Jiang H; Yao M; Li YM; Gu WJ; Shen YC; Qiu LW; Wu W; Wu XH; Sai WL
    Hepatobiliary Pancreat Dis Int; 2009 Aug; 8(4):407-13. PubMed ID: 19666411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression profiling of fixed tissues identified hypoxia-inducible factor-1α, VEGF, and matrix metalloproteinase-2 as biomarkers of lymph node metastasis in hepatocellular carcinoma.
    Xiang ZL; Zeng ZC; Fan J; Tang ZY; Zeng HY; Gao DM
    Clin Cancer Res; 2011 Aug; 17(16):5463-72. PubMed ID: 21712445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased ID2 promotes metastatic potentials of hepatocellular carcinoma by altering secretion of vascular endothelial growth factor.
    Tsunedomi R; Iizuka N; Tamesa T; Sakamoto K; Hamaguchi T; Somura H; Yamada M; Oka M
    Clin Cancer Res; 2008 Feb; 14(4):1025-31. PubMed ID: 18281534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rac activation is associated with hepatocellular carcinoma metastasis by up-regulation of vascular endothelial growth factor expression.
    Lee TK; Poon RT; Yuen AP; Man K; Yang ZF; Guan XY; Fan ST
    Clin Cancer Res; 2006 Sep; 12(17):5082-9. PubMed ID: 16951224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone morphogenetic protein 4 is induced in hepatocellular carcinoma by hypoxia and promotes tumour progression.
    Maegdefrau U; Amann T; Winklmeier A; Braig S; Schubert T; Weiss TS; Schardt K; Warnecke C; Hellerbrand C; Bosserhoff AK
    J Pathol; 2009 Aug; 218(4):520-9. PubMed ID: 19431154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inducible expression of hypoxia-inducible factor 1alpha on the proliferation and invasion property of HepG2 cells under normoxia in vitro].
    Jin WD; Chen XP; Yang SL; Xu ZQ; Zhang WG
    Zhonghua Wai Ke Za Zhi; 2007 Dec; 45(23):1634-6. PubMed ID: 18453222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Underexpressed microRNA-199b-5p targets hypoxia-inducible factor-1α in hepatocellular carcinoma and predicts prognosis of hepatocellular carcinoma patients.
    Wang C; Song B; Song W; Liu J; Sun A; Wu D; Yu H; Lian J; Chen L; Han J
    J Gastroenterol Hepatol; 2011 Nov; 26(11):1630-7. PubMed ID: 21557766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Introduction of in vitro transcribed ENO1 mRNA into neuroblastoma cells induces cell death.
    Ejeskär K; Krona C; Carén H; Zaibak F; Li L; Martinsson T; Ioannou PA
    BMC Cancer; 2005 Dec; 5():161. PubMed ID: 16359544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of extracellular signal-regulated kinase/mitogen-activated protein kinase pathway in multidrug resistance of hepatocellular carcinoma].
    Zhu H; Chen XP; Luo SF; Guan J; Zhang WG; Zhang BX; Mao CP
    Zhonghua Wai Ke Za Zhi; 2007 Jul; 45(13):917-20. PubMed ID: 17953842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of beta-catenin by hypoxia in hepatocellular carcinoma contributes to enhanced metastatic potential and poor prognosis.
    Liu L; Zhu XD; Wang WQ; Shen Y; Qin Y; Ren ZG; Sun HC; Tang ZY
    Clin Cancer Res; 2010 May; 16(10):2740-50. PubMed ID: 20460486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Up-regulation of the hypoxia-inducible factor-1 transcriptional pathway in colorectal carcinomas.
    Furlan D; Sahnane N; Carnevali I; Cerutti R; Bertoni F; Kwee I; Uccella S; Bertolini V; Chiaravalli AM; Capella C
    Hum Pathol; 2008 Oct; 39(10):1483-94. PubMed ID: 18619649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression pattern of angiogenic factors and prognosis after hepatic resection in hepatocellular carcinoma: importance of angiopoietin-2 and hypoxia-induced factor-1 alpha.
    Wada H; Nagano H; Yamamoto H; Yang Y; Kondo M; Ota H; Nakamura M; Yoshioka S; Kato H; Damdinsuren B; Tang D; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Nakamori S; Sakon M; Dono K; Wakasa K; Monden M
    Liver Int; 2006 May; 26(4):414-23. PubMed ID: 16629644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granulin-epithelin precursor overexpression promotes growth and invasion of hepatocellular carcinoma.
    Cheung ST; Wong SY; Leung KL; Chen X; So S; Ng IO; Fan ST
    Clin Cancer Res; 2004 Nov; 10(22):7629-36. PubMed ID: 15569995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expressions of hepatitis B virus x protein and hypoxia-inducible factor-1alpha in hepatocellular carcinoma and their possible relationships].
    Liu KG; Xie HH; Liu J
    Zhonghua Gan Zang Bing Za Zhi; 2007 Feb; 15(2):122-6. PubMed ID: 17362638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of cell cycle/growth regulator genes in human hepatocellular carcinoma and adjacent normal liver tissues.
    Liu LX; Jiang HC; Liu ZH; Zhu AL; Zhang WH; Wu LF; Zhou J; Wang XQ; Wu M
    Oncol Rep; 2003; 10(6):1771-5. PubMed ID: 14534694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression profiling of human HBV- and/or HCV-associated hepatocellular carcinoma cells using expressed sequence tags.
    Yoon SY; Kim JM; Oh JH; Jeon YJ; Lee DS; Kim JH; Choi JY; Ahn BM; Kim S; Yoo HS; Kim YS; Kim NS
    Int J Oncol; 2006 Aug; 29(2):315-27. PubMed ID: 16820872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NDRG1 as a biomarker for metastasis, recurrence and of poor prognosis in hepatocellular carcinoma.
    Cheng J; Xie HY; Xu X; Wu J; Wei X; Su R; Zhang W; Lv Z; Zheng S; Zhou L
    Cancer Lett; 2011 Nov; 310(1):35-45. PubMed ID: 21763068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antisense hypoxia-inducible factor 1alpha gene therapy enhances the therapeutic efficacy of doxorubicin to combat hepatocellular carcinoma.
    Liu F; Wang P; Jiang X; Tan G; Qiao H; Jiang H; Krissansen GW; Sun X
    Cancer Sci; 2008 Oct; 99(10):2055-61. PubMed ID: 19016766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wnt/β-catenin signaling enhances hypoxia-induced epithelial-mesenchymal transition in hepatocellular carcinoma via crosstalk with hif-1α signaling.
    Zhang Q; Bai X; Chen W; Ma T; Hu Q; Liang C; Xie S; Chen C; Hu L; Xu S; Liang T
    Carcinogenesis; 2013 May; 34(5):962-73. PubMed ID: 23358852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.